Indonesia · Delayed Price · Currency is IDR IDX:LABS Statistics
Total Valuation
IDX:LABS has a market cap or net worth of IDR 473.40 billion. The enterprise value is 494.11 billion.
| Market Cap | 473.40B |
| Enterprise Value | 494.11B |
Important Dates
The next estimated earnings date is Tuesday, March 30, 2027.
| Earnings Date | Mar 30, 2027 |
| Ex-Dividend Date | n/a |
Share Statistics
IDX:LABS has 3.91 billion shares outstanding. The number of shares has decreased by -0.95% in one year.
| Current Share Class | 3.91B |
| Shares Outstanding | 3.91B |
| Shares Change (YoY) | -0.95% |
| Shares Change (QoQ) | -0.95% |
| Owned by Insiders (%) | 9.97% |
| Owned by Institutions (%) | n/a |
| Float | 700.57M |
Valuation Ratios
The trailing PE ratio is 54.23.
| PE Ratio | 54.23 |
| Forward PE | n/a |
| PS Ratio | 2.24 |
| PB Ratio | 3.16 |
| P/TBV Ratio | 3.23 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 39.23 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 57.50 |
| EV / Sales | 2.34 |
| EV / EBITDA | 17.34 |
| EV / EBIT | 27.36 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.68, with a Debt / Equity ratio of 0.16.
| Current Ratio | 2.68 |
| Quick Ratio | 0.86 |
| Debt / Equity | 0.16 |
| Debt / EBITDA | 0.84 |
| Debt / FCF | n/a |
| Interest Coverage | 14.73 |
Financial Efficiency
Return on equity (ROE) is 5.77% and return on invested capital (ROIC) is 7.26%.
| Return on Equity (ROE) | 5.77% |
| Return on Assets (ROA) | 5.23% |
| Return on Invested Capital (ROIC) | 7.26% |
| Return on Capital Employed (ROCE) | 11.89% |
| Weighted Average Cost of Capital (WACC) | 4.47% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 54 |
| Asset Turnover | 0.98 |
| Inventory Turnover | 1.57 |
Taxes
In the past 12 months, IDX:LABS has paid 4.02 billion in taxes.
| Income Tax | 4.02B |
| Effective Tax Rate | 31.50% |
Stock Price Statistics
The stock price has decreased by -15.97% in the last 52 weeks. The beta is 0.05, so IDX:LABS's price volatility has been lower than the market average.
| Beta (5Y) | 0.05 |
| 52-Week Price Change | -15.97% |
| 50-Day Moving Average | 153.56 |
| 200-Day Moving Average | 151.01 |
| Relative Strength Index (RSI) | 30.40 |
| Average Volume (20 Days) | 1,083,325 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, IDX:LABS had revenue of IDR 214.40 billion and earned 8.73 billion in profits. Earnings per share was 2.23.
| Revenue | 214.40B |
| Gross Profit | 82.96B |
| Operating Income | 18.34B |
| Pretax Income | 12.74B |
| Net Income | 8.73B |
| EBITDA | 28.52B |
| EBIT | 18.34B |
| Earnings Per Share (EPS) | 2.23 |
Balance Sheet
The company has 3.67 billion in cash and 24.38 billion in debt, with a net cash position of -20.71 billion or -5.29 per share.
| Cash & Cash Equivalents | 3.67B |
| Total Debt | 24.38B |
| Net Cash | -20.71B |
| Net Cash Per Share | -5.29 |
| Equity (Book Value) | 152.05B |
| Book Value Per Share | 38.86 |
| Working Capital | 111.40B |
Cash Flow
In the last 12 months, operating cash flow was 12.27 billion and capital expenditures -20.51 billion, giving a free cash flow of -8.24 billion.
| Operating Cash Flow | 12.27B |
| Capital Expenditures | -20.51B |
| Depreciation & Amortization | 10.45B |
| Net Borrowing | -5.47B |
| Free Cash Flow | -8.24B |
| FCF Per Share | -2.11 |
Margins
Gross margin is 38.69%, with operating and profit margins of 8.56% and 4.07%.
| Gross Margin | 38.69% |
| Operating Margin | 8.56% |
| Pretax Margin | 5.94% |
| Profit Margin | 4.07% |
| EBITDA Margin | 13.30% |
| EBIT Margin | 8.56% |
| FCF Margin | n/a |
Dividends & Yields
IDX:LABS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 0.95% |
| Shareholder Yield | 0.95% |
| Earnings Yield | 1.84% |
| FCF Yield | -1.71% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
IDX:LABS has an Altman Z-Score of 7.18 and a Piotroski F-Score of 6.
| Altman Z-Score | 7.18 |
| Piotroski F-Score | 6 |